Results 11 to 20 of about 6,781 (204)

Disseminated Strongyloidiasis in Association with Nephrotic Syndrome [PDF]

Case Reports in Nephrology and Dialysis, 2018
Strongyloidiasis is a well-known parasitic infection endemic in tropical and subtropical areas of the world. While most infected individuals are asymptomatic, strongyloidiasis-related glomerulopathy has not been well documented.
Amirahwaty Abdullah, Lydia Winnicka, Charumathi Raghu, Violeta Zeykan, Jagmeet Singh   +4 more
doaj   +2 more sources

Twenty-five Years of Chronic Strongyloidiasis in an Immigrant

Clinical Medicine Insights: Case Reports, 2017
Chronic strongyloidiasis is an infection of the tropical regions, caused by the nematode Strongyloides stercoralis . In the United States, patients are typically immigrants.
Junior D Kalambay, Rehana Zaman, Mohammed H Zaman, Taufiq Zaman   +3 more
doaj   +2 more sources

Duodenal strongyloidiasis infection mimicking lymphangiectasia

Asian Journal of Medical Sciences, 2017
Strongyloides stercoralis infection usually causes a chronic asymptomatic intestinal infection or otherwise non-specific generalized complaints. The diagnosis of strongyloidiasis by routine stool examination is very limited.
Muhammad Bilal
doaj   +2 more sources

Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases

BMC Infectious Diseases, 2017
Background Strongyloidiasis is a chronic parasitic infection caused by Strongyloides stercoralis. Severe cases such as, hyperinfection syndrome (HS) and disseminated strongyloidiasis (DS), can involve pulmonary manifestations.
Daijiro Nabeya, Shusaku Haranaga, Gretchen Lynn Parrott, Takeshi Kinjo, Saifun Nahar, Teruhisa Tanaka, Tetsuo Hirata, Akira Hokama, Masao Tateyama, Jiro Fujita   +9 more
doaj   +2 more sources

Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia [PDF]

Oman Medical Journal, 2023
The use of immunosuppressive agents has recently been raised during the COVID-19 pandemic to manage the COVID-19-induced systemic inflammatory response and improve mortality.
Noora Al Busaidi, Fatma Al Farsi, Huda Al Batashi, Masoud Salim Kashoub, Ahmed Al Sinani, Zakariya Al Balushi, Faryal Khamis   +6 more
doaj   +2 more sources

International Survey on Screening and Management of Strongyloidiasis in Solid Organ Transplant Patients. [PDF]

Transpl Infect Dis
This international cross‐sectional survey of healthcare workers caring for solid organ transplant patients identified knowledge gaps regarding Strongyloides transmission and mortality, particularly among non‐infectious disease providers. Screening strategies varied geographically, with universal screening more common in endemic areas and targeted ...
Simkins J, Ravindra A, Wolfe CR, Mularoni A, Slavin M, Ushiro-Lumb I, Baddley JW, Hand J, Pouch S, Malinis M, Freire MP, Radisic M, Roberts MB, Tan BH, Watcharananan S, Clemente WT.   +15 more
europepmc   +2 more sources

Megaduodenum associated with gastric strongyloidiasis [PDF]

, 2020
Gastric strongyloidiasis and megaduodenum are rare diseases. Gastrointestinal (GI) strongyloidiasis has many clinical features. One of them is megaduodenum.
Lopes, Luiz Roberto, Andreollo, Nelson Adami, Carvalheiro da Silva, Amanda Pinter, Boteon, Yuri Longatto, Tercioti, Valdir, Coelho Neto, Joao de Souza   +5 more
core   +4 more sources

Exploring an Infectious Disease Service Pathway for Unaccompanied Asylum-Seeking Children: An Audit and Retrospective Analysis. [PDF]

Int J Pediatr
Unaccompanied asylum‐seeking children (UASC) experience a high burden of infectious diseases (IDs) and are a highly vulnerable population group with significant mental, physical, social and developmental needs. However, currently in the United Kingdom, there is no framework regarding how to implement ID screening guidance for UASC, leading to a wide ...
Tarn H, Bond M.
europepmc   +2 more sources

Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol

Pathogens, 2021
Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis.
Fernando Salvador, Ana Lucas-Dato, Silvia Roure, Marta Arsuaga, Asunción Pérez-Jacoiste, Magdalena García-Rodríguez, José A. Pérez-Molina, Dora Buonfrate, José María Saugar, Israel Molina   +9 more
doaj   +1 more source

A Rare Case of Strongyloides stercoralis Hyperinfection in a Diabetic Patient from Romania—Case Report and Review of the Literature

Pathogens, 2023
Severe cases of strongyloidiasis are most often associated with multiple causes of immune suppression, such as corticoid treatment and HTLV (human T-lymphotropic virus) coinfection.
Carmen Costache, Ioana Alina Colosi, Vlad Sever Neculicioiu, Diana Ioana Florian, Bobe Petrushev, Alexandra Vasvari, Andrada Seicean   +6 more
doaj   +1 more source